Comments

Biohaven Stock Price, Quotes and Forecasts

Q: What sector and industry does Biohaven (BHVN) operate in?

Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

BHVNNYSE

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$28.54

0.361.28%

At close: -

$28.54

0.000.00%

After Hours: Mar 21, 4:00 PM EDT

Biohaven (BHVN) Forecast

News Earnings Biohaven (BHVN) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Biohaven Stock Price, Quotes and Forecasts | NYSE:BHVN | Benzinga

Explore Biohaven stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BHVN.

Open	$27.76
Close	$28.54
Volume / Avg.	1.09M / 1.00M
Day Range	$27.21 - $28.88
52 Wk Range	26.80 - 60.46
Market Cap	$2.91B
P/E Ratio	-
Dividend Yield	-
Exchange	NYSE
RSI	34
Short Interest	9.17%
Days to Cover	11.69

Recent News

Strong Immunoglobulin Reduction Data Positions Biohaven's BHV-1300 As Potential Autoimmune Therapy

Biohaven's BHV-1300 reduced IgG levels by up to 84% in a Phase 1 trial for autoimmune disease, with rapid and sustained effects and a favorable safety profile.

Vandana Singh

Tesla Rebounds While Tariffs Weigh On Manufacturing: What's Driving Markets Monday?

Stocks fell broadly on Monday to start the month of March with all three major indices red in midday trading. Investors digested a decline in February's ISM Manufacturing PMI data which fell to 50.3%, down from 50.9% in January.

Erica Kollmann

Financial Crime Weekly: Pfizer Pays Nearly $60 Million To Resolve False Claims Allegations, SEC Creates Crypto Task Force

The DOJ announces Pfizer agreed to pay nearly $60 million to resolve false claims allegations. The SEC creates a task force dedicated to the development of a clear and comprehensive regulatory framework for crypto assets.

Erica Kollmann

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$27.76
Close	$28.54
Volume / Avg.	1.09M / 1.00M
Day Range	$27.21 - $28.88
52 Wk Range	26.80 - 60.46
Market Cap	$2.91B
P/E Ratio	-
Dividend Yield	-
Exchange	NYSE
RSI	34
Short Interest	9.17%
Days to Cover	11.69

About Biohaven Ltd

Sector

Health Care

Industry

Biotechnology

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, an...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Biohaven (BHVN) stock?

You can purchase shares of Biohaven (NYSE:BHVN) through any online brokerage.

View our list of the best stock brokerages

Who are Biohaven (BHVN) competitors?

Other companies in Biohaven’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE) and MoonLake (NASDAQ:MLTX).

What is the forecast, or price target, for Biohaven (BHVN) stock?

Biohaven has a consensus price target of $68.82.

What is the current price for Biohaven (BHVN)?

The stock price for Biohaven (NYSE: BHVN) is $28.54 last updated March 21, 2025 at 4:00 PM EDT.

Does Biohaven (BHVN) pay a dividend?

There are no upcoming dividends for Biohaven.

When is Biohaven (NYSE:BHVN) reporting earnings?

Biohaven’s Q1 earnings are confirmed for Thursday, May 8, 2025.

Is Biohaven (BHVN) going to split?

There is no upcoming split for Biohaven.

What sector and industry does Biohaven (BHVN) operate in?

Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.